Divis Laboratories Ltd Share Price – NSE  / BSE

Pharmaceuticals, Mid Cap

Divis Laboratories Ltd is up for a third straight session today. The stock is quoting at Rs 4884.75, up 3.42% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.12% on the day, quoting at 24728.5. The Sensex is at 80764.15, down 0.05%. Divis Laboratories Ltd has gained around 7.72% in last one month.

Meanwhile, Nifty Pharma index of which Divis Laboratories Ltd is a constituent, has gained around 9.29% in last one month and is currently quoting at 22374.25, up 0.83% on the day. The volume in the stock stood at 10.29 lakh shares today, compared to the daily average of 6.01 lakh shares in last one month.

The benchmark August futures contract for the stock is quoting at Rs 4881, up 3.44% on the day. Divis Laboratories Ltd is up 33.71% in last one year as compared to a 27.49% jump in NIFTY and a 47.43% jump in the Nifty Pharma index.

The PE of the stock is 75.46 based on TTM earnings ending June 24.

Powered by Capital Market - Live News

Revenue from operations grew by 19.12% year on year to Rs 2,118 crore in the quarter ended 30 June 2024.

Profit before tax for the quarter was at Rs 604 crore, up 22.76% from Rs 492 crore reported in the same period a year ago.

Total expense stood at Rs 1593 crore in Q1 FY25, up 16.53% on YoY basis. Cost of material consumed was at Rs 893 crore (up 7.72% YoY) and employee benefit expenses stood at Rs 292 crore (up 11.03% YoY) during the period under review.

Forex loss for the current quarter amounted to Rs 1 crore as against a gain of Rs 3 crore posted in Q1 FY24.

On standalone basis, the company’s net profit surged 24.64% to Rs 430 crore on 19.25% rise in revenue to Rs 2,063 crore in Q1 FY25 over Q1 FY24.

Divis Laboratories is engaged in the manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients.

Shares of Divis Laboratories gained 1.40% to end at Rs 4,990.35 on Friday, 2 August 2024.

Powered by Capital Market - Live News

Net profit of Divi's Laboratories rose 20.79% to Rs 430.00 crore in the quarter ended June 2024 as against Rs 356.00 crore during the previous quarter ended June 2023. Sales rose 19.12% to Rs 2118.00 crore in the quarter ended June 2024 as against Rs 1778.00 crore during the previous quarter ended June 2023.

Powered by Capital Market - Live News

Divis Laboratories will hold a meeting of the Board of Directors of the Company on 3 August 2024.

Powered by Capital Market - Live News